|
|
| | DAABD-AE Basic information |
| Product Name: | DAABD-AE | | Synonyms: | DAABD-AE;4-[2-(N,N-Dimethylamino)ethylaminosulfonyl]-7-(2-aminoethylamino)-2,1,3-benzoxadiazole;4-[2-(N,N-Dimethylamino)ethylsulfamoyl]-7-(2-aminoethylamino)benzofurazan;7-[(2-Aminoethyl)amino]-N-[2-(dimethylamino)ethyl]-2,1,3-benzoxadiazole-4-sulfonamide;7-[(2-Aminoethyl)amino]-n-[2-(dimethylamino)ethyl]-2,1,3-benzoxadiazole-4-sulfonamide Benzoxadiazole-4-sulfonamide;2,1,3-Benzoxadiazole-4-sulfonamide, 7-[(2-aminoethyl)amino]-N-[2-(dimethylamino)ethyl]- | | CAS: | 913253-56-2 | | MF: | C12H20N6O3S | | MW: | 328.39 | | EINECS: | | | Product Categories: | | | Mol File: | 913253-56-2.mol |  |
| | DAABD-AE Chemical Properties |
| Melting point | 138-139 °C | | Boiling point | 528.3±60.0 °C(Predicted) | | density | 1.369±0.06 g/cm3(Predicted) | | storage temp. | 2-8°C | | pka | 7.56±0.50(Predicted) |
| | DAABD-AE Usage And Synthesis |
| Uses | DAABD-AE is used to quantify the presence of 3-?hydroxyglutaric acid (3HGA) in dried urine spots to diagnose glutaric aciduria type 1 using LC-?MS?/MS. |
| | DAABD-AE Preparation Products And Raw materials |
|